Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Mar 28, 2025; 17(3): 104917
Published online Mar 28, 2025. doi: 10.4329/wjr.v17.i3.104917
Published online Mar 28, 2025. doi: 10.4329/wjr.v17.i3.104917
Enhancing lymphoma staging: Unveiling the potential and challenges of whole-body magnetic resonance imaging
Mohadese Ahmadzade, Department of Radiology, Baylor College of Medicine, Houston, TX 77030, United States
Mohammad Ghasemi-Rad, Department of Radiology, Section of Interventional Radiology, Baylor College of Medicine, Houston, TX 77030, United States
Author contributions: Ahmadzade M and Ghasemi-Rad M conceptualized and designed the editorial; Ahmadzade M performed the literature review and drafted the manuscript. Ghasemi-Rad M provided critical revisions and final approval. All authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare no conflicts of interest related to this manuscript.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Mohammad Ghasemi-Rad, MD, PhD, Department of Radiology, Section of Interventional Radiology, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, United States. mdghrad@gmail.com
Received: January 6, 2025
Revised: March 6, 2025
Accepted: March 12, 2025
Published online: March 28, 2025
Processing time: 80 Days and 4.8 Hours
Revised: March 6, 2025
Accepted: March 12, 2025
Published online: March 28, 2025
Processing time: 80 Days and 4.8 Hours
Core Tip
Core Tip: Whole-body magnetic resonance imaging (WB-MRI) has revolutionized oncological imaging by offering a radiation-free alternative for comprehensive disease assessment across various malignancies. The integration of diffusion-weighted imaging enhances lesion detection and staging accuracy, positioning WB-MRI as a promising alternative to conventional imaging methods like computed tomography and FDG-PET. Despite its high diagnostic performance, the clinical adoption of WB-MRI has been limited due to insufficient prospective data and challenges in patient acceptance.